U.S. flag

An official website of the United States government

NM_000492.3(CFTR):c.1210-17_1210-12del AND Cystic fibrosis

Germline classification:
Benign/Likely benign (2 submissions)
Last evaluated:
Jan 30, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001510196.13

Allele description [Variation Report for NM_000492.3(CFTR):c.1210-17_1210-12del]

NM_000492.3(CFTR):c.1210-17_1210-12del

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
CFTR-AS1:CFTR antisense RNA 1 [Gene - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.3(CFTR):c.1210-17_1210-12del
HGVS:
  • NC_000007.13:g.117188661_117188666del
  • NC_000007.14:g.117548608GT[8]
  • NG_016465.4:g.87825GT[8]
  • NM_000492.3:c.1210-17_1210-12del6
  • NM_000492.4:c.1210-34TG[8]MANE SELECT
  • LRG_663t1:c.1210-17_1210-12del
  • LRG_663:g.87825GT[8]
  • NC_000007.13:g.117188661_117188666del
  • NC_000007.13:g.117188662GT[8]
  • NC_000007.13:g.117188678_117188683delGTGTGT
  • NM_000492.3:c.1210-17_1210-12del
  • NM_000492.3:c.1210-17_1210-12del6
  • NM_000492.3:c.1210-17_1210-12delGTGTGT
Links:
dbSNP: rs3832534
NCBI 1000 Genomes Browser:
rs3832534
Molecular consequence:
  • NM_000492.4:c.1210-34TG[8] - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Cystic fibrosis (CF)
Synonyms:
Mucoviscidosis
Identifiers:
MONDO: MONDO:0009061; MedGen: C0010674; Orphanet: 586; OMIM: 219700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001717170Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Dec 9, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005035753Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Jan 30, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001717170.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Ambry Genetics, SCV005035753.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 15, 2024